Share |
Press Releases 2015
December 21, 2015 at 4:00 pm

Verisante Provides Operational Update


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in skin cancer detection technology, provides an operational update. Verisante is pleased to announce the Company has placed an Aura™ at the Restore Vein and Skin Centre in Kelowna, BC (“Restore”).  Restore...

Full story

July 9, 2015 at 1:30 pm

Verisante Enters Amended Licensing Agreement with the BC Cancer Agency


HIRES FULLTIME SCIENTIST FROM BCCA VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in skin cancer detection technology, announced today that it has entered into an agreement that amends the licensing agreement (the “Agreement”) originally entered into with the BC...

Full story

July 3, 2015 at 2:32 pm

Verisante Provides Operational Update


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in skin cancer detection technology, provides a mid-year operational update. Verisante is pleased to announce that the Company has received a purchase order from the Nova Scotia Health Authority for an Aura™,...

Full story

March 12, 2015 at 2:00 pm

Verisante Obtains Mexican Approval


AURA RECEIVES APPROVAL FROM COFEPRIS, A DIVISION WITHIN THE MEXICAN MINISTRY OF HEALTH TO MARKET AND SELL VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in skin cancer detection technology, announced today that it has received regulatory approval from the...

Full story

February 18, 2015 at 2:00 pm

Verisante Technology, Inc. Announces Equipment Loan to Further Collaboration with Key Chinese Laboratory


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today it has expanded its collaboration with Fujian Normal University in China (the “University”).  Verisante has signed an equipment loan agreement with the Key Laboratory of Optoelectronic...

Full story

January 13, 2015 at 1:30 pm

Verisante Technology, Inc. Announces Brain Tumour Study in the UK


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today it has entered into a collaboration with the BC Cancer Agency and Imperial College Healthcare NHS Trust to develop a new application for the Company’s exclusively licensed...

Full story

  Back to top